Digital Library
Close Browse articles from a journal
 
<< previous    next >>
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
           All articles of the corresponding issues
                                       Details for article 45 of 48 found articles
 
 
  Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study
 
 
Title: Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study
Author: Cho, Byoung Chul
Abreu, Delvys Rodriguez
Hussein, Maen
Cobo, Manuel
Patel, Anjan J
Secen, Nevena
Lee, Ki Hyeong
Massuti, Bartomeu
Hiret, Sandrine
Yang, James Chih Hsin
Barlesi, Fabrice
Lee, Dae Ho
Ares, Luis Paz
Hsieh, Robert W
Patil, Namrata S
Twomey, Patrick
Yang, Xiaoying
Meng, Raymond
Johnson, Melissa L
Appeared in: Lancet oncology
Paging: Volume 23 () nr. 6 pages 781-792
Year: 2022
Contents:
Publisher: Elsevier Ltd
Source file: Elektronische Wetenschappelijke Tijdschriften
 
 

                             Details for article 45 of 48 found articles
 
<< previous    next >>
 
 Koninklijke Bibliotheek - National Library of the Netherlands